Psyched Wellness Ltd · CSE:PSYC
Psyched Wellness — Investor Presentation (March 2023)
17 slides from Psyched Wellness's investor presentation, Mar 16, 2023
Slide 1: Corporate Deck
Deck Corporate moc.ssenllew-dehcysp@ofni | moc.ssenllew-dehcysp.www | moc.ssenllew-dehcysp.pohs.www
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This document and the material contained herein are confidential and are not to be disclosed to the public. This is for information purposes only and may not be reproduced or distributed to any other person or published, in whole or part, for any purpose whatsoever. Certain
Slide 3: Our Company
Our Company CSE: PSYC OTCQB: PSYCF FRANKFURT: 5U9 A M A N I TA M U S CA R I A Psyched Wellness is a Canadian-based life sciences company focused on the research and development of a legal psychedelic mushroom: Amanita Muscaria We are led by a strong team with experts in all key streams, from R&D to
Slide 4: Meet Our Mushroom
Meet Our Mushroom History Regulatory Result Easily the most recognizable Amanita Muscaria has Our AME-1 product line mushroom in the world. The never been classified as a has multiple applications red and white “fairytale fungi” scheduled drug in North harnessing this is represented in Alice in Amer
Slide 5: The First to Market
The First to Market We have launched the first legal Amanita Muscaria mushroom product in North America. “Calm” is the only AME-1 product approved for sale as a food supplement, in the USA. It is designed to help you get the rest you need. The over-the-counter sleep category continues to grow. Rest
Slide 6: Uncapped Retail Universe
Uncapped Retail Universe Phase 1 – Priority Segments Unlike Psilocybin or Cannabis, our Amanita Muscaria Tincture with AME-1 will be available for sale at traditional retailers, without a prescription. This means Psyched Wellness has the potential to sell our products to hundreds of thousands of rel
Slide 7: Next Up
Next Up First, we establish our routes-to- market and retailer landscape…then we expand assortment “Calm” is the first of a diverse portfolio of product applications. Alongside our phenomenal CMO partner we are readying skus in the capsule, gummy, and tea verticals. Additionally, we are investigatin
Slide 8: White Label and Private Label Opportunities
White Label and Private Label Opportunities There’s more! AME-1 bulk wholesale empowers partner organizations while also building Psyched revenue + additional awareness of the Amanita Muscaria mushroom. Psyched Wellness will sell our proprietary extract to partner organizations for use in strategic
Slide 9: Investment Highlights
Investment Highlights First Mover Expedited Path Global Market to Market & Revenue Opportunity As the only public company As a food supplement via Amanita Muscaria is not a studying and the GRAS certification in restricted mushroom in many commercializing Amanita the USA and Health countries. Intern
Slide 10: Achievements & Next Steps
Achievements & Next Steps Q1 2022 Q2 2022 Q3 2022 Q3 2022 Q4 2022 • Launch a new website (desktop • GRAS approval for the USA • Commence R&D on Psyched • Submit the application for the AME- and mobile) Wellness’ sleep aid tea - AME-1 & 1 as a NHP to Health Canada • Host a digital summit to introduce
Slide 11: Achievements & Next Steps
Achievements & Next Steps • Psyched Wellness will finalize its R&D process and will start sales of its first flagship Amanita Muscaria tincture in the USA via a GRAS certification and will apply to sell in Canada as a Natural Health Product (NHP). • This will be the first psychedelic food supplement tha
Slide 12: Leadership Team
Leadership Team Jeffrey Stevens, CEO David Shisel, COO Matthew Singh, CCO Keith Li, CFO Mr. Stevens has 20+ years of Mr. Shisel is an Mr. Singh is a seasoned Consumer Mr. Li is a CPA, CA with 10+ capital markets experience entrepreneur specializing in Packaged Goods (CPG) executive with years experi
Slide 13: Board of Directors
Board of Directors Michael Nederhoff, Chairman Terry Booth David Nutt Currently acts as President of JUUL Labs in Global cannabis industry pioneer and David Nutt is a psychiatrist and the Edmond J. Canada overseeing Canadian operations founder of Aurora Cannabis (TSX-ACB). Safra Professor of Neurops
Slide 14: Board of Directors
Board of Directors Nick Kadysh Janeen Stodulski Amanda Galbraith Head of Corporate Affairs at JUUL Labs Canada. MA graduate of Brock University, Janeen received her CPA Amanda Galbraith is one of Canada’s foremost crisis Formerly served as Government Affairs & designation in 1999 and her MBA from Qu
Slide 15: Advisory Board
Advisory Board Dawn DeCunha Dr. Andrew Kohler Brian Tancowny Dr. Dawn DeCunha is a clinical psychologist, with an Dr. Kohler is the founder and owner of Callingwood Mr. Brian Tancowny has over 25 years of experience active practice in Toronto, Canada. She is a graduate of Crossing Medical Center, wh
Slide 16: Capital Structure
Capital Structure Common Shares 130,589,695 Warrants 24,806,365 Options 12,875,000 Fully Diluted Issued and Outstanding 177,571,060 CSE: PSYC OTCQB: PSYCF FRANKFURT: 5U9
Slide 17: Contact
Contact Address 77 King St West Toronto, Ontario, Canada M5K 1G8 Jeff Stevens CEO & Director jstevens@psyched-wellness.com 1(647)400-8494
Psyched Wellness — Investor Presentation (March 2023) on 6ix